US Stock MarketDetailed Quotes

ORKA Oruka Therapeutics

Watchlist
  • 21.940
  • +0.620+2.91%
Close Dec 13 16:00 ET
  • 21.940
  • 0.0000.00%
Post 20:01 ET
767.87MMarket Cap-57.74P/E (TTM)

About Oruka Therapeutics Company

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

Company Profile

SymbolORKA
Company NameOruka Therapeutics
Listing DateAug 8, 1997
CEODr. Lawrence Otto Klein, PhD
MarketNASDAQ
Fiscal Year Ends12-31
Address855 Oak Grove Avenue,Suite 100
CityMenlo Park
ProvinceCalifornia
CountryUnited States of America
Zip Code94025
Phone1-650-606-7910
Websitehttp://www.orukatx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Lawrence Otto Klein, PhD
  • Director, President and Chief Executive Officer
  • --
  • Dr. Joana Goncalves, M.D.
  • Chief Medical Officer
  • --
  • Arjun Agarwal
  • Senior Vice President, Finance and Treasurer
  • --
  • Dr. Samarth Kulkarni, PhD
  • Chairman of the Board
  • --
  • Peter Harwin
  • Independent Director
  • --
  • Dr. Cameron Turtle, D.Phil.
  • Independent Director
  • --
  • Kristine M. Ball
  • Independent Director
  • --
  • Dr. Carl Dambkowski, M.D.
  • Independent Director
  • --
  • Paul T. Quinlan PhD
  • General Counsel and Secretary
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data